Nasdaq Top Companies List by Market Cap as of January 2024

Nasdaq Top Companies List by Market Cap as of Jan-05-2024, Nasdaq Biggest 500 Companies List by Market Cap, Nasdaq Largest 500 Companies List by market cap as of Jan-05-2024.
Nasdaq Largest and Top 1,000 Companies List in 2024
Nasdaq Largest 1,000 Companies List by Market Cap in 2024, Nasdaq Top 1,000 Companies List by Market Cap in 2024.
Stock Exchange Website
Nasdaq

  1. Celcuity

    World Rank (Jan-05-2024)
    14,725
    Market Cap (Jan-05-2024)
    0.354 Billion USD
    World Rank (Jul-30-2023)
    17,562
    Market Cap (Jul-30-2023)
    0.220 Billion USD
    World Rank (Dec-25-2022)
    18,055
    Market Cap (Dec-25-2022)
    0.199 Billion USD
    World Rank (Jan-07-2022)
    19,198
    Market Cap (Jan-07-2022)
    0.19 Billion USD
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    CELCUITY

  2. Performant Financial Corporation

    World Rank (Jan-05-2024)
    17,355
    Market Cap (Jan-05-2024)
    0.221 Billion USD
    World Rank (Jul-30-2023)
    17,574
    Market Cap (Jul-30-2023)
    0.219 Billion USD
    World Rank (Dec-25-2022)
    17,203
    Market Cap (Dec-25-2022)
    0.234 Billion USD
    World Rank (Jan-07-2022)
    20,462
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    PERFORMANT FINANCIAL CORPORATION

  3. Southern States Bancshares Inc.

    World Rank (Jan-05-2024)
    16,702
    Market Cap (Jan-05-2024)
    0.252 Billion USD
    World Rank (Jul-30-2023)
    17,603
    Market Cap (Jul-30-2023)
    0.218 Billion USD
    World Rank (Dec-25-2022)
    17,033
    Market Cap (Dec-25-2022)
    0.241 Billion USD
    World Rank (Jan-07-2022)
    19,789
    Market Cap (Jan-07-2022)
    0.18 Billion USD
    Headquarters Country
    USA
    Company Website
    SOUTHERN STATES BANCSHARES, INC.

  4. Stratus Properties

    World Rank (Jan-05-2024)
    17,339
    Market Cap (Jan-05-2024)
    0.222 Billion USD
    World Rank (Jul-30-2023)
    17,617
    Market Cap (Jul-30-2023)
    0.218 Billion USD
    World Rank (Dec-25-2022)
    19,314
    Market Cap (Dec-25-2022)
    0.157 Billion USD
    World Rank (Jan-07-2022)
    16,980
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Annual Revenue in USD
    61 Million USD
    Annual Net Income in USD
    -23 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    STRATUS PROPERTIES

  5. Rani Therapeutics Holdings Inc.

    World Rank (Jan-05-2024)
    18,975
    Market Cap (Jan-05-2024)
    0.163 Billion USD
    World Rank (Jul-30-2023)
    17,620
    Market Cap (Jul-30-2023)
    0.217 Billion USD
    World Rank (Dec-25-2022)
    15,586
    Market Cap (Dec-25-2022)
    0.306 Billion USD
    World Rank (Jan-07-2022)
    16,098
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Headquarters Country
    USA
    Company Website
    RANI THERAPEUTICS HOLDINGS, INC.

  6. Kamada

    World Rank (Jan-05-2024)
    14,811
    Market Cap (Jan-05-2024)
    0.349 Billion USD
    World Rank (Jul-30-2023)
    17,620
    Market Cap (Jul-30-2023)
    0.217 Billion USD
    World Rank (Dec-25-2022)
    18,836
    Market Cap (Dec-25-2022)
    0.172 Billion USD
    World Rank (Jan-07-2022)
    16,798
    Market Cap (Jan-07-2022)
    0.30 Billion USD
    Headquarters Country
    Israel
    Yahoo @ Israel
    Company Website
    KAMADA

  7. Bankwell Financial Group

    World Rank (Jan-05-2024)
    17,201
    Market Cap (Jan-05-2024)
    0.228 Billion USD
    World Rank (Jul-30-2023)
    17,624
    Market Cap (Jul-30-2023)
    0.217 Billion USD
    World Rank (Dec-25-2022)
    17,400
    Market Cap (Dec-25-2022)
    0.225 Billion USD
    World Rank (Jan-07-2022)
    17,411
    Market Cap (Jan-07-2022)
    0.27 Billion USD
    Annual Revenue in USD
    58 Million USD
    Annual Net Income in USD
    6 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Website
    BANKWELL FINANCIAL GROUP

  8. BCB Bancorp

    World Rank (Jan-05-2024)
    17,443
    Market Cap (Jan-05-2024)
    0.218 Billion USD
    World Rank (Jul-30-2023)
    17,637
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    15,591
    Market Cap (Dec-25-2022)
    0.305 Billion USD
    World Rank (Jan-07-2022)
    17,395
    Market Cap (Jan-07-2022)
    0.27 Billion USD
    Annual Revenue in USD
    89 Million USD
    Annual Net Income in USD
    20 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    BCB BANCORP

  9. LianBio American Depositary Shares

    World Rank (Jan-05-2024)
    13,238
    Market Cap (Jan-05-2024)
    0.451 Billion USD
    World Rank (Jul-30-2023)
    17,654
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    18,679
    Market Cap (Dec-25-2022)
    0.177 Billion USD
    World Rank (Jan-07-2022)
    13,160
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -196 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    LianBio is a biopharmaceutical company that treat the specific cause of diseases like cardiovascular, oncology and respiratory. The company total assets are 279.2 million USD as on 2020. The headquarters is in USA.

    Company Website
    LIANBIO

  10. Inozyme Pharma Inc.

    World Rank (Jan-05-2024)
    16,447
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    17,663
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    25,394
    Market Cap (Dec-25-2022)
    0.048 Billion USD
    World Rank (Jan-07-2022)
    20,454
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    USA
    Company Profile
    Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
    Company Website
    INOZYME PHARMA, INC.

Share